[Clinical features of essential thrombocythemia in three children].
Essential thrombocythemia (ET) is one of the quite rare myeloproliferative disorders in children. The natural course and outcome of this disease have been reported to vary. We report three children (two boys and one girl, mean age at diagnosis 12 yr) with ET who showed different clinical courses. The girl was asymptomatic, but the boys had ankle pain and priapism, respectively. The platelet count ranged between 2300 and 2900 x 10(9)/L, and the diagnoses were made according to the criteria of the Polycythemia Vera Study Group. The serum thrombopoietin level reached 0.33 and 0.47 fmol/ml in two patients. All three children were administered aspirin or dipyridamole orally. Normalization of the platelet count was observed in two patients, and stable disease persisted in one. The 12 pediatric patients with ET reported previously in Japan demonstrated a low incidence of serious thrombohemorrhagic complications and a favorable outcome, none developing acute leukemia. Careful continuous observation and conservative treatment may be preferable in pediatric patients who do not have cardiovascular symptoms, avoiding the use of potential leukemogens such as alkylating agents and hydroxyurea.
Kudo
K
K
Division of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital.
Horibe
K
K
Iwase
K
K
Kondo
M
M
Kojima
S
S
D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D013920:Thrombocythemia, Essential / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D013926:Thrombopoietin / Q000097:blood
D004176:Dipyridamole; D013926:Thrombopoietin; D001241:Aspirin